Poly(d,l-lactide-co-glycolide)–chitosan composite particles for the treatment of lung cancer

Tumor heterogeneity makes combination chemotherapy one of the preferred modes of treatment regimens. In this work, sequential exposure of two anticancer agents, paclitaxel (Tx) followed by topotecan (TPT), was shown to have a synergistic effect on non-small cell lung cancer (NSCLC) cell line, NCI-H4...

Descripción completa

Detalles Bibliográficos
Autores principales: Arya, Neha, Katti, Dhirendra S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406260/
https://www.ncbi.nlm.nih.gov/pubmed/25945047
http://dx.doi.org/10.2147/IJN.S78120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406260/
https://www.ncbi.nlm.nih.gov/pubmed/25945047
http://dx.doi.org/10.2147/IJN.S78120

Ejemplares similares